Baidu
map

Prognostic clinical factors in patients affected by non-small-cell lung cancer receiving Nivolumab

Pantano, F; Russano, M; Berruti, A; Mansueto, G; Migliorino, MR; Adamo, V; Aprile, G; Gelibter, A; Ficorella, C; Falcone, A; Russo, A; Aieta, M; Maio, M; Martelli, O; Barni, S; Napolitano, A; Roca, E; Quadrini, S; Iacono, D; Russo, A; Calvetti, L; Occhipinti, MA; Cortellini, A; Vasile, E; Passiglia, F; Imperatori, M; Calabro, L; Di Giacomo, AM; Petrelli, F; Pasquini, G; Franchina, T; Venditti, O; Intagliata, S; Galvano, A; Fioroni, I; Vincenzi, B; Tonini, G; Santini, D

Russano, M (corresponding author), Univ Campus Biomed, Dept Med Oncol, Via Alvaro Del Portillo 200, I-00128 Rome, Italy.

EXPERT OPINION ON BIOLOGICAL THERAPY, 2020; 20 (3): 319

Abstract

Background: Immune-checkpoint inhibitors have radically changed the treatment landscape of Non-Small-Cell Lung Cancer (NSCLC). It is still unclear whe......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

Baidu
map
Baidu
map
Baidu
map